Patents by Inventor Julie Marill

Julie Marill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000940
    Abstract: The invention concerns a particle and a composition comprising particles and their use in oncology. Specifically, the particles are porous, high-Z and carbon-free particles having internal pores, of longest dimension of at least 0.5 nm, and are for use in altering or destroying target cells in a mammal when said cells are exposed to ionizing radiation. The present invention also provides a porous, high-Z and carbon-free particle wherein at least part of the porous structure of the particle is occupied by at least one therapeutic agent which is preferably for use in oncology.
    Type: Application
    Filed: November 30, 2021
    Publication date: January 4, 2024
    Inventors: LAURENT LEVY, CÉLINE BERJAUD, ALEXANDRA MADEIRA, JULIE MARILL, MARIE-EDITH MEYRE
  • Publication number: 20210353670
    Abstract: The present invention relates to the field of human health and more particularly concerns nanoparticles for use as a therapeutic vaccine in the context of radiotherapy in a subject suffering of a cancer, in particular of a metastatic cancer or of a liquid cancer.
    Type: Application
    Filed: July 29, 2021
    Publication date: November 18, 2021
    Inventors: JULIE MARILL, AGNÈS POTTIER, LAURENT LEVY
  • Patent number: 11096962
    Abstract: The present invention relates to the field of human health and more particularly concerns nanoparticles for use as a therapeutic vaccine in the context of radiotherapy in a subject suffering of a cancer, in particular of a metastatic cancer or of a liquid cancer.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: August 24, 2021
    Assignee: NANOBIOTIX
    Inventors: Julie Marill, Agnes Pottier, Laurent Levy
  • Publication number: 20180147237
    Abstract: The present invention relates to the field of human health and more particularly concerns nanoparticles for use as a therapeutic vaccine in the context of radiotherapy in a subject suffering of a cancer, in particular of a metastatic cancer or of a liquid cancer.
    Type: Application
    Filed: May 27, 2016
    Publication date: May 31, 2018
    Inventors: JULIE MARILL, AGNES POTTIER, LAURENT LEVY
  • Patent number: 8845507
    Abstract: The present application relates to novel excitable particles which can be used in the health sector. It more particularly relates to particles which can generate electrons and/or high energy photon when excited by ionizing radiations such as X-Rays, ?-Rays, radioactive isotope and/or electron beams, and to the uses thereof in health, in particular in human health. The inventive particles are made of an inorganic material comprising oxygen, in particular an oxide, said material having an adequate density, and can be activated in vitro, ex vivo, or in vivo, by controllable external excitation, in order to disturb, alter or destroy target cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or medical device compositions containing same.
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: September 30, 2014
    Assignee: Nanobiotix
    Inventors: Laurent Levy, Agnes Pottier, Annabelle Rouet, Julie Marill, Corinne Devaux, Matthieu Germain
  • Publication number: 20110213192
    Abstract: The present application relates to novel excitable particles which can be used in the health sector. It more particularly relates to particles which can generate electrons and/or high energy photon when excited by ionizing radiations such as X- Rays, ?-Rays, radioactive isotope and/or electron beams, and to the uses thereof in health, in particular in human health. The inventive particles are made of an inorganic material comprising oxygen, in particular an oxide, said material having an adequate density, and can be activated in vitro, ex vivo, or in vivo, by controllable external excitation, in order to disturb, alter or destroy target cells, tissues or organs. The invention also relates to methods for the production of said particles, and to pharmaceutical or medical device compositions containing same.
    Type: Application
    Filed: June 4, 2009
    Publication date: September 1, 2011
    Applicant: NANOBIOTIX
    Inventors: Laurent Levy, Agnes Pottier, Annabelle Rouet, Julie Marill, Corinne Devaux, Matthieu Germain